Hola,
Are you new here?

I have an account

¿Te ayudamos?

Ejemplos de búsqueda

Vídeos Explicativos

EVCA

financed

Closed

Centre for Excellence in Diagnostic and Advanced Therapeutics based on Extracell...

Centre for Excellence in Diagnostic and Advanced Therapeutics based on Extracellular Vesicles In recent years, extracellular vesicles (EVs) have emerged within the scientific community for both biomarkers and therapeutic applications. However, the translation of the research findings represents a major challenge for biomed... see more

31/10/2025

UNL

1M€

Project Budget: 1M€

Project leader

UNIVERSIDADE NOVA DE LISBOA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 5 Participantes

Financing granted El organismo HORIZON EUROPE notifico la concesión del proyecto The day 2022-09-09

HORIZON-WIDERA-2021-ACCESS-03-01: Twinning Expected Outcome:To prevent further disparities, maximize investment in R&D and enhance economic...

Innovación

Cerrada does 3 years

0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

UNL

918.87K€ | Leader

INSERM

44.60K€ | participant

ASOCIACION CENTRO DE INVESTI...

208.00K€ | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 37 months Date Start: 2022-09-09
End date: 2025-10-31

Project leader

UNIVERSIDADE NOVA DE LISBOA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 1M€

participation deadline Sin fecha límite de participación.

Project description In recent years, extracellular vesicles (EVs) have emerged within the scientific community for both biomarkers and therapeutic applications. However, the translation of the research findings represents a major challenge for biomedical research and healthcare. International cooperation is paramount to moving research findings to clinical applications and defining standard operating procedures. EVCA addresses this unmet need through a scientific strategy to reinforce research and innovation (R&I) excellence in the study of EV applications in diagnosis, therapeutics, and etiology of chronic diseases. The Chronic Diseases Research Center of the NOVA Medical School (UNL) aims to be at the forefront of international scientific excellence in applying EVs to diagnostic and therapeutic clinical priority challenges in chronic diseases. Towards this goal, UNL is twinning with the CIC bioGUNE (Spain) and Institut Curie (France), international references in EVs. EVCA will leverage on the partners’ outstanding multidisciplinary knowledge, experience, research and training best practices, as well as collaborative networks, to enhance the research capacity and innovation potential of UNL. EVCA is an integrated network of interactions (exchange and training of researchers, satellite meetings, Winter Retreats, virtual think tanks, links to industry, etc.), articulated with the individual and joint scientific agendas of the partners to power the research capacity of UNL and of its R&I ecosystems. EVCA expects to increase by 25% in multiple indicators by 2026, including the number of citations; h-index of UNL researchers; percentage of publications in top impact journals; number of international collaborations (including with industry). By stimulating novel and long-lasting interactions between the partners, EVCA will unlock the research potential within and outside UNL, with an overall increase in the Portuguese and European RD research competitiveness.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers